LPL Financial
MIST icon

LPL Financial’s Milestone Pharmaceuticals MIST Stock Holding History

LPL Financial’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$296K Buy
220,873
+27,500
+14% +$44K ﹤0.01% 5472
2026
Q1 		$230K Buy
193,373
+50,910
+36% +$89.1K ﹤0.01% 5391
2025
Q4 		$288K Buy
142,463
+47,163
+49% +$102K ﹤0.01% 5173
2025
Q3 		$191K Buy
95,300
+84,250
+762% +$148K ﹤0.01% 5362
2025
Q2 		$21.4K Sell
11,050
-100,490
-90% -$134K ﹤0.01% 5464
2025
Q1 		$89.2K Buy
+111,540
New +$222K ﹤0.01% 5068

Other funds holding MIST

PCM
Pavaki Capital Management Pueblo, Colorado $287M AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

LPL Financial's MIST Position: Q2 2026 in Review

LPL Financial increased its Milestone Pharmaceuticals (MIST) stake by 14% in Q2 2026, buying an estimated $44K and bringing the position to 220,873 shares worth $296K. The position accounts for ﹤0.01% of the portfolio, ranked #5472.

LPL Financial first reported a position in MIST in Q1 2025 and has held it in 6 quarters since. 78 funds tracked by Wall St. Rank hold MIST as of Q2 2026.

  • LPL Financial held 220,873 shares of Milestone Pharmaceuticals worth $296K as of Q2 2026.
  • LPL Financial bought 27,500 Milestone Pharmaceuticals shares in Q2 2026, an estimated $44K.
  • Milestone Pharmaceuticals made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #5472 holding.
  • LPL Financial first reported a position in Milestone Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 78 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.